| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |